PTSD, a Disorder with an Immunological Component
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Post-traumatic stress disorder (PTSD) has been associated with an inflammatory state. However, few studies have addressed the mechanisms underlying this immune imbalance that favors inflammation or how this imbalance contributes to PTSD. Whether the immune imbalance influences responsiveness or unresponsiveness of patients to PTSD treatments is currently not known. This review brings forward an immune emphasis to a mental health disorder that is unprecedented in its prevalence among combat Veterans of the ongoing conflicts in Iraq and Afghanistan and which also afflicts civilians who have undergone extreme traumatic experiences, such as following natural disasters, serious accidents, or assaults. Included is an overview of the correlative associations in human subjects between PTSD and inflammation and studies in animal models of PTSD, demonstrating causal contributions of inflammation and immune dysregulation to PTSD-like behavior following stress exposure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Passage of cytokines across the blood–brain barrier
Banks, W. A., Kastin, A. J., & Broadwell, R. D. (1996) · Neuroimmunomodulation · doi:10.1159/000097202 · Cited by 778
Trends in mental illness and suicidality after Hurricane Katrina
Kessler, R. C., Galea, S., Gruber, M. J., Sampson, N. A., Ursano, R. J., & Wessely, S. (2008) · Molecular Psychiatry · doi:10.1038/sj.mp.4002119 · Cited by 617
von Känel, R., Hepp, U., Kraemer, B., Traber, R., Keel, M., Mica, L., & Schnyder, U. (2007) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.06.009 · Cited by 408 · cited 10×
“For example, immune mediators, such as IL-1, IL-6, and TNF-α, are able to cross the blood–brain barrier, and this is one way in which peripheral immune reactivity can have CNS impacts (48).”
InfluentialAssessment of Plasma C-Reactive Protein as a Biomarker of Posttraumatic Stress Disorder Risk
Eraly, S. A., Nievergelt, C. M., Maihofer, A. X., Barkauskas, D. A., Biswas, N., Agorastos, A., O’Connor, D. T., & Baker, D. G. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.4374 · Cited by 386 · cited 1×
“A prospective study of deployed Marines showed that pre-deployment levels of C-reactive protein, an indicator of inflammation, predicted post-deployment PTSD and suggested inflammation to be a contributor to PTSD (32).”
Pace, T. W. W., & Heim, C. M. (2011) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.10.003 · Cited by 321
Wohleb, E. S., McKim, D. B., Shea, D. T., Powell, N. D., Tarr, A. J., Sheridan, J. F., & Godbout, J. P. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.11.029 · Cited by 300
The role of the innate immune system in psychiatric disorders
Jones, K. A., & Thomsen, C. (2013) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.10.002 · Cited by 274
PTSD is associated with an excess of inflammatory immune activities
Gill, J. M., Saligan, L., Woods, S., & Page, G. (2009) · Perspectives in Psychiatric Care · doi:10.1111/j.1744-6163.2009.00229.x · Cited by 271
Plasma and Cerebrospinal Fluid Interleukin-6 Concentrations in Posttraumatic Stress Disorder
Baker, D. G., Ekhator, N. N., Kasckow, J. W., Hill, K. K., Zoumakis, E., Dashevsky, B. A., Chrousos, G. P., & Geracioti Jr., T. D. (2001) · Neuroimmunomodulation · doi:10.1159/000049028 · Cited by 238 · cited 1×
“However, the results of such studies are conflicting, with demonstrations of both increases and no difference in levels of IL-6 among subjects with and without PTSD (33, 34).”
Gola, H., Engler, H., Sommershof, A., Adenauer, H., Kolassa, S., Schedlowski, M., Groettrup, M., Elbert, T., & Kolassa, I.-T. (2013) · BMC Psychiatry · doi:10.1186/1471-244x-13-40 · Cited by 225
Cazareth, J., Guyon, A., Heurteaux, C., Chabry, J., & Petit-Paitel, A. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-132 · Cited by 206
Pace, T. W. W., Wingenfeld, K., Schmidt, I., Meinlschmidt, G., Hellhammer, D. H., & Heim, C. M. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.07.232 · Cited by 184
Substantial reduction of naïve and regulatory T cells following traumatic stress
Sommershof, A., Aichinger, H., Engler, H., Adenauer, H., Catani, C., Boneberg, E.-M., Elbert, T., Groettrup, M., & Kolassa, I.-T. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.07.003 · Cited by 172 · cited 10×
“For example, immune mediators, such as IL-1, IL-6, and TNF-α, are able to cross the blood–brain barrier, and this is one way in which peripheral immune reactivity can have CNS impacts (48).”
InfluentialZhou, J., Nagarkatti, P., Zhong, Y., Ginsberg, J. P., Singh, N. P., Zhang, J., & Nagarkatti, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094075 · Cited by 171 · cited 9×
“For example, immune mediators, such as IL-1, IL-6, and TNF-α, are able to cross the blood–brain barrier, and this is one way in which peripheral immune reactivity can have CNS impacts (48).”
InfluentialTucker, P., Ruwe, W. D., Masters, B., Parker, D. E., Hossain, A., Trautman, R. P., & Wyatt, D. B. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.03.009 · Cited by 148 · cited 2×
“For example, blood levels of the inflammatory mediator IL-1 declined from an increased level in individuals with PTSD to levels comparable to those of controls following treatment with sertraline (43).”
Transcriptional Control of Monocyte Gene Expression in Post-Traumatic Stress Disorder
O’Donovan, A., Sun, B., Cole, S., Rempel, H., Lenoci, M., Pulliam, L., & Neylan, T. (2011) · Disease Markers · doi:10.1155/2011/560572 · Cited by 141
Sympathetic Release of Splenic Monocytes Promotes Recurring Anxiety Following Repeated Social Defeat
McKim, D. B., Patterson, J. M., Wohleb, E. S., Jarrett, B. L., Reader, B. F., Godbout, J. P., & Sheridan, J. F. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.07.010 · Cited by 137 · cited 1×
“In mice that were exposed to repeated social defeat, subthreshold stress resulted in trafficking of primed monocytes from the spleen to the brain and re-establishment of anxiety behavior (58, 59).”
Study on serum cytokine levels in posttraumatic stress disorder patients
Guo, M., Liu, T., Guo, J.-C., Jiang, X.-L., Chen, F., & Gao, Y.-S. (2012) · Asian Pacific Journal of Tropical Medicine · doi:10.1016/s1995-7645(12)60048-0 · Cited by 113 · cited 1×
“However, in a separate study, both inflammatory and anti-inflammatory cytokines were shown to be elevated in PTSD subjects, leading to a conclusion of a generalized immune activated state in PTSD (27).”
Glatt, S. J., Tylee, D. S., Chandler, S. D., Pazol, J., Nievergelt, C. M., Woelk, C. H., Baker, D. G., Lohr, J. B., Kremen, W. S., Litz, B. T., et al. (2013) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32167 · Cited by 80
Cohen, M., Meir, T., Klein, E., Volpin, G., Assaf, M., & Pollack, S. (2011) · The International Journal of Psychiatry in Medicine · doi:10.2190/pm.42.2.b · Cited by 78 · cited 9×
“For example, immune mediators, such as IL-1, IL-6, and TNF-α, are able to cross the blood–brain barrier, and this is one way in which peripheral immune reactivity can have CNS impacts (48).”
InfluentialTelomere shortening and immune activity in war veterans with posttraumatic stress disorder
Jergović, M., Tomičević, M., Vidović, A., Bendelja, K., Savić, A., Vojvoda, V., Rac, D., Lovrić-Čavar, D., Rabatić, S., Jovanovic, T., et al. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2014.06.010 · Cited by 67 · cited 1×
“Levels of the negative regulator PD-L1 on CD4+ cells from PTSD patients are also reduced, further illustrating the immune skewing toward a dysregulated state (28).”
Emotions, immunity and sport: Winner and loser athlete’s profile of fighting sport
Pesce, M., Fratta, I. L., Ialenti, V., Patruno, A., Ferrone, A., Franceschelli, S., Rizzuto, A., Tatangelo, R., Campagna, G., Speranza, L., et al. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.02.013 · Cited by 44
Smid, G. E., van Zuiden, M., Geuze, E., Kavelaars, A., Heijnen, C. J., & Vermetten, E. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2014.07.010 · Cited by 38 · cited 1×
“Because of the direct association between skewed immune reactivity toward increased levels of inflammatory cytokines and disease severity in combat-exposed Veterans with PTSD, it has been suggested that immune activation is a contributor to their clinical status (20).”
Cited by
Yuan, N., Chen, Y., Xia, Y., Dai, J., & Liu, C. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0570-y · Cited by 428
Imaging the Role of Inflammation in Mood and Anxiety-related Disorders
Felger, J. C. (2018) · Current Neuropharmacology · doi:10.2174/1570159x15666171123201142 · Cited by 427
Metabolism, Metabolomics, and Inflammation in Posttraumatic Stress Disorder
Mellon, S. H., Gautam, A., Hammamieh, R., Jett, M., & Wolkowitz, O. M. (2018) · Biological Psychiatry · doi:10.1016/j.biopsych.2018.02.007 · Cited by 184
Metabolomic analysis of male combat veterans with post traumatic stress disorder
Mellon, S. H., Bersani, F. S., Lindqvist, D., Hammamieh, R., Donohue, D., Dean, K., Jett, M., Yehuda, R., Flory, J., Reus, V. I., et al. (2019) · PLOS ONE · doi:10.1371/journal.pone.0213839 · Cited by 85
Lambert, M., Ruppelt, F., Siem, A.-K., Rohenkohl, A. C., Kraft, V., Luedecke, D., Sengutta, M., Schröter, R., Daubmann, A., Correll, C. U., et al. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2017.07.036 · Cited by 29
Metadata
- Authors
- Wang, Z., & Young, M. R. I.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2016-06-06
- Volume
- 7
- Pages
- 219-219
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W2417295330
- Cited by
- 61
- References
- 23
- FWCI
- 10.83
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.